Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.
about
Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritisThe transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats.Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin depositionTadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in PodocytesSildenafil improves renal function in patients with pulmonary arterial hypertension.Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled TrialC-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells.New approaches to the treatment of nephropathy in diabetes.Emerging drugs for managing kidney disease in patients with diabetes.Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.Nitric oxide in the normal kidney and in patients with diabetic nephropathy.Phosphodiesterase type 5 inhibitors and kidney disease.Reversibility of endothelial dysfunction in diabetes: role of polyphenols.Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic ratsChanges in the pharmacokinetic of sildenafil citrate in rats with Streptozotocin-induced diabetic nephropathy.Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition.Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.
P2860
Q34797271-BEE0962F-F394-441B-9454-DC50B09939D4Q35116422-97E1AA6E-196E-4661-A67B-D575CD11D749Q35191172-C435FE5A-6B43-4974-A41A-F848BE615994Q35395483-5F234DCD-9ECB-4069-8EF5-7F6829C9372CQ35583071-67027ED2-F4AA-42D3-A5BF-B1C40ACB4035Q35972212-8568273F-28E2-4438-9AEE-F7A476039752Q36339950-D4785015-97F6-421B-9D82-54A87130E5F4Q37581535-076BB23D-B43A-4157-8E3F-E38A81274770Q37899907-9D14D1F0-7C02-447A-B940-CCB6A02FF51DQ38075029-E6275296-1D1C-4B50-984F-0655A3D12EFDQ38130262-35ACE432-5A56-41B3-A910-9547E56661A1Q38248725-1F1E0E90-3E7D-47F7-A02F-EAC093F582E3Q38560737-B3EDF920-C899-4771-A57C-944BD580834AQ38855635-8B50E419-B566-4A4A-B905-30160FE4D9CBQ41330819-64096EF3-A068-4803-8E4A-0A69BFD5026FQ41951810-AC11BDC0-0B94-4071-BBEF-B523A7F11A71Q42125804-73193CF6-7A58-4FA4-8714-6E72C0899214Q42722900-FE1186A9-348C-4595-89D0-2C11F16908FFQ43633024-39B1B4F6-1C5C-4D3A-900A-982084A94398Q47260733-1F4BC370-E42D-4451-BC3D-297DF9923570Q51299126-B1695BFF-7697-4137-AD3C-A06CF72C7D3CQ55113144-DE43F10D-91E4-4E9F-B94F-11E92F1A2B61
P2860
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@en
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@nl
type
label
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@en
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@nl
prefLabel
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@en
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@nl
P2093
P2860
P1476
Sildenafil, a phosphodiesteras ...... ng-Evans Tokushima Fatty rats.
@en
P2093
Masayuki Iyoda
Tadao Akizawa
Takanori Shibata
Yoshihiro Kuno
Yuki Hirai
P2860
P304
P356
10.1111/J.1476-5381.2010.01149.X
P407
P577
2011-03-01T00:00:00Z